文献速递乳房整形与再造显微修复重建

腹壁下动脉穿支皮瓣乳房重建中供区多点肌内注射罗哌卡因可减轻疼痛

Multiple intramuscular ropivacaine injections to donor sites reduces pain in deep inferior epigastric artery perforator flap breast reconstruction.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2024-08-21

本研究对比65例在DIEP皮瓣乳房重建中接受供区肌内多点注射0.75%罗哌卡因20毫升(20个位点)的患者与55例未注射罗哌卡因的患者。结果显示罗哌卡因组术后前5天VAS评分显著更低(p<0.001),前24小时VAS下降更快(p=0.045),住院时间更短(p=0.001),阿片类药物消耗无差异,未观察到注射相关并发症。

要点

  • 供区肌内多点注射罗哌卡因可降低DIEP重建术后前5天VAS评分。
  • 罗哌卡因组术后前24小时VAS评分下降速度更快。
  • 两组阿片类药物消耗相当,罗哌卡因组住院时间更短且无注射相关并发症。

核心结论

  • 供区肌内多点注射罗哌卡因可能减轻DIEP皮瓣乳房重建术后疼痛并缩短住院时间,且不增加阿片类药物消耗。

研究设计与样本

  • 研究纳入2022年3月至2023年2月期间接受DIEP重建并局部注射罗哌卡因的65例患者,与2018年10月至2020年7月未使用罗哌卡因的55例患者进行比较。
  • 将20毫升0.75%罗哌卡因溶液均匀注射于腹壁肌肉20个位点,采用线性混合效应模型评估术后VAS评分,并比较阿片类药物消耗和住院天数。

主要发现

  • 罗哌卡因组每日VAS评分中位数均更低(所有p值<0.001)。
  • 线性混合效应模型分析显示,罗哌卡因组术后前5天VAS评分显著更低(p值<0.001)。
  • 罗哌卡因组术后前24小时VAS评分下降速度更快(p值=0.045)。
  • 两组阿片类药物消耗相当,但罗哌卡因组住院时间显著更短(p值=0.001),未观察到注射相关并发症。

临床怎么用

  • 作者认为,供区肌内多点注射罗哌卡因可能减轻DIEP皮瓣乳房重建术后疼痛并缩短住院时间,且不增加阿片类药物消耗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Local anesthetic infiltration at the surgical site has been studied in various surgical disciplines; however, its impact on deep inferior epigastric artery perforator (DIEP) flap breast reconstruction has not been previously assessed. This study aimed to evaluate the effects of multiple intramuscular ropivacaine injections on donor site pain during DIEP flap breast reconstruction. METHODS: The study included 65 patients who received local ropivacaine injections during DIEP reconstructions between March 2022 and February 2023, compared to 55 patients who underwent surgeries without ropivacaine from October 2018 to July 2020. A total of 20 cc of 0.75% ropivacaine solution was evenly administered at 20 sites along the abdominal wall muscles. The effect of intramuscular ropivacaine injection on postoperative visual analog scale (VAS) was evaluated using linear mixed-effect model. Opioid consumption and hospital days were also compared. RESULTS: The daily median VAS score was lower in the ropivacaine group (all p-values < 0.001). When analyzed using a linear mixed-effects model, those who received ropivacaine had significantly lower VAS scores over the first 5 days postoperatively (p-value < 0.001). The rate of VAS score decline was also faster in the ropivacaine group over the first 24 h postoperative (p-value = 0.045). Although opioid consumption was comparable between the groups, those receiving ropivacaine had significantly shorter hospital stay (p-value = 0.001) and no complications related to the injections were observed. CONCLUSION: Multiple intramuscular injections of ropivacaine to the donor site may reduce postoperative pain and shorten hospital stays, without increasing opioid consumption.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Bae J, Shin DR, Sohn JY, et al. Multiple intramuscular ropivacaine injections to donor sites reduces pain in deep inferior epigastric artery perforator flap breast reconstruction. J Plast Reconstr Aesthet Surg. 2024. PMID: 39243715. doi:10.1016/j.bjps.2024.08.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。